$IART News

Integra LifeSciences Holdings Corporation (IART) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Integra LifeSciences Holdings Corporation 2026 Q1 - Results - Earnings Call Presentation

Citigroup Maintains Sell on Integra Lifesciences, Raises Price Target to $11

Wells Fargo Maintains Equal-Weight on Integra Lifesciences, Raises Price Target to $15

Integra LifeSciences Holdings Corporation (IART) Q1 2026 Earnings Call Transcript

Integra Lifesciences Q1 2026 Earnings Call Transcript

Integra Lifesciences Sees Q2 Adj EPS $0.44-$0.52 vs $0.53 Est; Sees Sales $410.000M-$425.000M vs $425.403M Est

Integra Lifesciences Raises FY2026 Adj EPS Guidance from $2.30-$2.40 to $2.40-$2.50 vs $2.35 Est; Affirms FY2026 Sales Guidance of $1.662B-$1.702B vs $1.674B Est

Integra Lifesciences Q1 Adj. EPS $0.54 Beats $0.41 Estimate, Sales $391.918M Beat $381.870M Estimate

Truist Securities Maintains Hold on Integra Lifesciences, Lowers Price Target to $12

Argus Research Downgrades Integra Lifesciences to Hold

Wells Fargo Maintains Equal-Weight on Integra Lifesciences, Lowers Price Target to $12

Integra LifeSciences shares are trading lower. The company reported Q4 financial results and issued Q1 guidance below estimates. The company also announced FY26 guidance.

Integra LifeSciences shares are trading lower. The company reported Q4 financial results and issued Q1 guidance below estimates. The company also announced FY26 guidance.

Integra LifeSciences (NASDAQ:IART) Beats Q4 2025 Earnings Estimates, Provides 2026 Outlook

Integra LifeSciences Holdings Corporation (IART) Q4 2025 Earnings Call Transcript

Integra LifeSciences Holdings Corporation 2025 Q4 - Results - Earnings Call Presentation

Integra Lifesciences Sees Q1 Adj EPS $0.37-$0.45 vs $0.48 Est; Sees Sales $375.000M-$390.000M vs $392.147M Est

Integra Lifesciences Sees FY2026 Adj EPS $2.30-$2.40 vs $2.35 Est; Sees Sales $1.662B-$1.702B vs $1.675B Est

Integra Lifesciences Q4 Adj. EPS $0.83 Beats $0.80 Estimate, Sales $434.925M Beat $429.621M Estimate